2-44942213-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005413.4(SIX3):​c.109G>T​(p.Gly37Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00231 in 1,589,978 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0023 ( 11 hom. )

Consequence

SIX3
NM_005413.4 missense

Scores

2
2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:3B:7

Conservation

PhyloP100: -0.103
Variant links:
Genes affected
SIX3 (HGNC:10889): (SIX homeobox 3) This gene encodes a member of the sine oculis homeobox transcription factor family. The encoded protein plays a role in eye development. Mutations in this gene have been associated with holoprosencephaly type 2. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010941207).
BP6
Variant 2-44942213-G-T is Benign according to our data. Variant chr2-44942213-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 30381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-44942213-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0021 (317/151256) while in subpopulation AMR AF= 0.00789 (120/15210). AF 95% confidence interval is 0.00674. There are 1 homozygotes in gnomad4. There are 177 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 317 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIX3NM_005413.4 linkc.109G>T p.Gly37Cys missense_variant Exon 1 of 2 ENST00000260653.5 NP_005404.1 O95343

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIX3ENST00000260653.5 linkc.109G>T p.Gly37Cys missense_variant Exon 1 of 2 1 NM_005413.4 ENSP00000260653.3 O95343

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
317
AN:
151146
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000581
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00790
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00254
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00129
AC:
299
AN:
231504
Hom.:
1
AF XY:
0.00124
AC XY:
157
AN XY:
126974
show subpopulations
Gnomad AFR exome
AF:
0.000403
Gnomad AMR exome
AF:
0.00180
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000171
Gnomad NFE exome
AF:
0.00207
Gnomad OTH exome
AF:
0.00120
GnomAD4 exome
AF:
0.00233
AC:
3356
AN:
1438722
Hom.:
11
Cov.:
32
AF XY:
0.00227
AC XY:
1623
AN XY:
715778
show subpopulations
Gnomad4 AFR exome
AF:
0.000333
Gnomad4 AMR exome
AF:
0.00156
Gnomad4 ASJ exome
AF:
0.000193
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000258
Gnomad4 NFE exome
AF:
0.00284
Gnomad4 OTH exome
AF:
0.00191
GnomAD4 genome
AF:
0.00210
AC:
317
AN:
151256
Hom.:
1
Cov.:
31
AF XY:
0.00240
AC XY:
177
AN XY:
73892
show subpopulations
Gnomad4 AFR
AF:
0.000580
Gnomad4 AMR
AF:
0.00789
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00254
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00208
Hom.:
0
Bravo
AF:
0.00216
ESP6500AA
AF:
0.000600
AC:
2
ESP6500EA
AF:
0.00246
AC:
18
ExAC
AF:
0.000940
AC:
111
EpiCase
AF:
0.00224
EpiControl
AF:
0.00167

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:3Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 12, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SIX3: BS1, BS2 -

Feb 11, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 18791198, 26080100, 20157829, 19346217) -

Holoprosencephaly 2 Pathogenic:1Benign:1
Mar 01, 2010
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Solitary median maxillary central incisor syndrome Pathogenic:1
-
Center for Human Genetics, University of Leuven
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Schizencephaly Pathogenic:1
Mar 01, 2010
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

not specified Benign:1
Mar 31, 2015
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Aug 09, 2021
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

SIX3-related disorder Benign:1
Jul 06, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
19
DANN
Benign
0.92
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.34
T
M_CAP
Pathogenic
0.73
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.0
N
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.44
N
REVEL
Uncertain
0.47
Sift
Benign
0.054
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.0
B
Vest4
0.20
MVP
0.61
MPC
1.1
ClinPred
0.0068
T
GERP RS
-0.74
Varity_R
0.12
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199823175; hg19: chr2-45169352; COSMIC: COSV105021536; COSMIC: COSV105021536; API